A carregar...
Molecular pathology of lung cancer: clinical aspects
Discovery of tyrosine kinase inhibitor sensitizing mutations in lung cancer (LC) appears to be the main event in clinical oncology of the last decade. Activating lesions in epidermal growth factor receptor (EGFR) gene almost guarantee tumor response to gefitinib, erlotinib or afatinib.ALK translocat...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2016-02-01
|
| Colecção: | Sibirskij Onkologičeskij Žurnal |
| Assuntos: | |
| Acesso em linha: | https://www.siboncoj.ru/jour/article/view/255 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|